Three reasons to stick with stocks despite rising yields, according to Barclays

Barclays advises investors to remain invested in equities rather than derisk, despite rising bond yields and spiking energy prices. The bank's strategists argue that headline risks should not override the case for maintaining stock exposure, signaling a cautiously constructive market stance.

Analysis

The relevant market question is not whether nominal yields are elevated, but whether real yields rise because growth is strengthening or because term premium and fiscal-supply pressure are repriced. The former can support cyclicals, banks and earnings-sensitive equities; the latter compresses long-duration multiples without an offsetting earnings upgrade. With index concentration still high, a broad equity allocation masks meaningful factor risk: mega-cap growth is most exposed to a further upward move in real yields, while value/cash-flow sectors offer better downside asymmetry.

Energy-driven inflation is a more material risk to margins than to headline index earnings initially. Consumer discretionary, transports and low-margin industrials face a lagged cost squeeze, whereas integrated energy and selected E&Ps retain direct operating leverage; the second-order concern is that sustained fuel inflation delays central-bank easing and raises discount rates across all equities. Over the next 1-3 months, the key catalyst is whether earnings revisions broaden beyond a narrow group of large-cap technology names; absent that broadening, equities can fall even if aggregate economic data remain resilient.

The contrarian case is that consensus is treating higher yields as uniformly bearish when the equity market may instead rotate rather than derate wholesale. A durable steepening driven by nominal growth would improve reinvestment economics for JPM, BAC and select insurers, while limiting the relative appeal of expensive defensives and long-duration software. This thesis fails if the 10-year real yield rises alongside widening credit spreads, declining PMIs, or negative forward EPS revisions—conditions that would signal a funding shock rather than healthy reflation.

Key Decisions for Investors

• Maintain equity beta but rotate exposure over the next 1-3 months: pair long XLE and KBE against short XLK or IWF in equal dollar amounts. The trade benefits from higher-for-longer rates and energy-price persistence; exit if 10-year real yields decline materially and energy prices reverse.
• Avoid using BCS as a direct expression of the macro view; the research stance has limited standalone earnings sensitivity for the stock. Treat BCS as a watch item only, with UK/EU investment-banking fee trends and credit-loss provisions more important than this strategist commentary.
• For concentrated growth exposure, buy 3-6 month QQQ put spreads rather than liquidating core equity holdings. This protects against a rate-led multiple reset while preserving upside if earnings revisions reaccelerate; the hedge should be reassessed if the 10-year yield rise is accompanied by tightening, rather than widening, credit spreads.
• Add an alert for forward 12-month S&P 500 EPS revisions and US high-yield spreads: if revisions turn negative while spreads widen above recent ranges, reduce cyclical/value rotation and cut net equity exposure, as the reflation interpretation would be falsified.